Company Filing History:
Years Active: 2016
Title: Esther Y Kim: Innovator in Renal Pharmacology
Introduction
Esther Y Kim is a prominent inventor based in Cheltenham, PA (US). She has made significant contributions to the field of renal pharmacology, particularly through her innovative work on potassium channel inhibitors.
Latest Patents
Esther holds a patent for her invention titled "Inhibitors of the renal outer medullary potassium channel." This invention relates to compounds of Formula I, which are designed to inhibit the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds are useful as diuretics and natriuretics, making them valuable for the therapy and prophylaxis of disorders resulting from excessive salt and water retention. These disorders include cardiovascular diseases such as hypertension and both chronic and acute heart failure. Esther has 1 patent to her name.
Career Highlights
Esther is currently associated with Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts in pharmacology. Her work has the potential to impact the treatment of various cardiovascular conditions significantly.
Collaborations
Esther has collaborated with notable colleagues, including Shawn P Walsh and Alexander Pasternak, to further her research initiatives and enhance the effectiveness of her inventions.
Conclusion
Esther Y Kim is a trailblazer in the field of renal pharmacology, with her innovative inventions paving the way for new therapeutic options in managing cardiovascular diseases. Her contributions are invaluable to the medical community and the patients who benefit from her work.